Evidence map›Paper›PMID 32503810›Full record

ArticleBMJ open diabetes research & care2020

Insulin pricing and other major diabetes-related concerns in the USA: a study of 46 407 tweets between 2017 and 2019.

Adrian Ahne, Francisco Orchard, Xavier Tannier, Camille Perchoux, Beverley Balkau, Sherry Pagoto, Jessica Lee Harding, Thomas Czernichow, Guy Fagherazzi

Abstract read
In one paragraph

Article in BMJ open diabetes research & care, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Adrian AhneCenter for Research in Epidemiology and Population Health (CESP), INSERM, University Paris Saclay, Villejuif (Paris), Île-de-France, France.
Francisco OrchardEpiconcept Company, Paris, France.
Xavier TannierLIMICS, INSERM U1142, Sorbonne University, Paris, Île-de-France, France.
Camille PerchouxLuxembourg Institute of Socio-Economic Research, Esch-sur-Alzette, Luxembourg.
Beverley BalkauCenter for Research in Epidemiology and Population Health (CESP), INSERM, University Paris Saclay, Villejuif (Paris), Île-de-France, France.
Sherry PagotoDepartment of Allied Health Sciences, UConn Center for mHealth & Social Media, University of Connecticut, Storrs, Connecticut, USA.
Jessica Lee HardingDivision of Transplantation, Department of Surgery, Emory University School of Medicine, Emory University Hospital, Atlanta, Georgia, USA.
Thomas CzernichowEpiconcept Company, Paris, France.
Guy FagherazziDigital Epidemiology Hub, Department of Population Health, Luxembourg Institute of Health, Strassen, Luxembourg Guy.Fagherazzi@lih.lu.ORCID 0000-0001-5033-5966

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionLittle research has been done to systematically evaluate concerns of people living with diabetes through social media, which has been a powerful tool for social change and to better understand perceptions around health-related issues. This study aims to identify key diabetes-related concerns in the USA and primary emotions associated with those concerns using information shared on Twitter. RESEARCH DESIGN AND

methodsA total of 11.7 million diabetes-related tweets in English were collected between April 2017 and July 2019. Machine learning methods were used to filter tweets with personal content, to geolocate (to the USA) and to identify clusters of tweets with emotional elements. A sentiment analysis was then applied to each cluster.

resultsWe identified 46 407 tweets with emotional elements in the USA from which 30 clusters were identified; 5 clusters (18% of tweets) were related to insulin pricing with both positive emotions (

conclusionsUsing social media data, we have been able to describe key diabetes-related concerns and their associated emotions. More specifically, we were able to highlight the real-world concerns of insulin pricing and its negative impact on mood. Using such data can be a useful addition to current measures that inform public decision making around topics of concern and burden among people with diabetes.

Indexed as

Diabetes MellitusSocial MediaCosts and Cost AnalysisEmotionsHumansInsulinUnited StatesInsulinemotionepidemiologymethodologypsychological stress

Identifiers

PMID32503810
PMCPMC7282343

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.